A novel temperature-controlled device with standardized manipulation improves chronic back pain mediated by modulating deep muscle thickness: A multicenter randomized controlled trial

Abstract

Background: Chronic back pain affected 619 million people globally in 2020 which accounts for a heavy disease burden causing tremendous productivity losses. Current therapies including ibuprofen, duloxetine, and opioids might cause side effects and even severe drug use disorders. Therefore, a non-pharmacologic therapy with better or equivalent efficacy and fewer side effects is needed.

Methods: We did a multi-center, single-blinded, randomized, positive drug controlled, clinical trial. Patients with chronic back pain in moderate severity were randomized into receiving hot stone massage or flurbiprofen plaster group. Both interventions were 2 weeks with a follow-up of 4 weeks. The primary outcome was the change in the score of the Global Pain Scale (GPS) from baseline to week 2. Secondary outcomes included Numerical Rating Scale (NRS), Chronic Pain Acceptance Questionnaire (CPAQ), Pain Self-Efficacy Questionnaire (PSEQ), Hospital Anxiety and Depression Scale (HADS), and Short Form-36 (SF36) from baseline to week 2 and week 6. Exploratory outcome assessment included the muscle thickness measured by ultrasound. Any adverse event was monitored throughout the study period.

Results: A total of 120 patients were enrolled in this trial. At 2 weeks GPS decreased significantly in the hot stone massage group compared to the flurbiprofen group (difference between groups = -8.1 points, 95% confidence interval [CI] -15.8 to -0.3, p = 0.047). Moreover, hot stone massage also showed more improvement at 2 weeks compared to flurbiprofen, including NRS (-0.5 points, 95% CI -1.0 to -0.1, p = 0.029), PSEQ (5.4 points, 95% CI 0.5 to 10.2, p = 0.030), and mental component of Short Form-36 (SF-36) (1.7 points, 95% CI 0.4 to 2.9, p = 0.010), but not in CPAQ (p = 0.131), HADS (p = 0.303 for depression, p = 0.399 for anxiety), or SF-36 (p = 0.129 for physical component, p = 0.246 for social component, p = 0.076 for fatigue component). A total of two participants in the hot stone massage group reported mild pain on skin surface when receiving the procedure at the first intervention session.

Keywords

chronic back pain / heat therapy / massage / pain management / randomized controlled trial

References

[1] Rheumatology TL. The global epidemic of low back pain. Lancet Rheumatol. 2023;5(6):e305.

[2] Tanguay-Sabourin C, Fillingim M, Guglietti GV, et al. A prognostic risk score for development and spread of chronic pain. Nat Med. 2023;29(7):1821-1831.

[3] Sommer C, Rittner H. Pain research in 2023: towards understanding chronic pain. Lancet Neurol. 2024;23(1):27-28.

[4] Stubhaug A, Hansen JL, Hallberg S, Gustavsson A, Eggen AE, Nielsen CS. The costs of chronic pain—Long-term estimates. Eur J Pain. 2024;28(6):960-977.

[5] Stein Emil V, Ababneh HS, Abate YH, et al. Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2204-2256.

[6] Chou R, Deyo R, Friedly J, et al. Systemic pharmacologic therapies for low back pain: a systematic review for an American College of Physicians clinical practice guideline. Ann Intern Med. 2017;166(7):480-492.

[7] US Centers for Disease Control and Prevention. Prevent opioid use disorder. Accessed March 12, 2024. Available from:

[8] Alford DP. Chronic back pain with possible prescription opioid misuse. JAMA. 2013;309(9):919-925.

[9] Jones KF, Mason DJ. The false dichotomy of pain and opioid use disorder. JAMA Health Forum. 2022;3(4):e221406.

[10] Foster NE, Anema JR, Cherkin D, et al. Prevention and treatment of low back pain: evidence, challenges, and promising directions. Lancet North Am Ed. 2018;391(10137):2368-2683.

[11] Chou R, Deyo R, Friedly J, et al. Nonpharmacologic therapies for low back pain: a systematic review for an American College of Physicians clinical practice guideline. Ann Intern Med. 2017;166(7):493-505.

[12] Kroll HR. Exercise therapy for chronic pain. Phys Med Rehabil Clin N Am. 2015;26(2):263-281.

[13] Ernst E. Adverse effects of spinal manipulation: a systematic review. J R Soc Med. 2007;100(7):330-338.

[14] Xu M, Yang C, Nian T, et al. Adverse effects associated with acupuncture therapies: an evidence mapping from 535 systematic reviews. Chin Med. 2023;18(1):38.

[15] Miake-Lye IM, Mak S, Lee J, et al. Massage for pain: an evidence map. J Altern Complement Med. 2019;25(5):475-502.

[16] Epstein AS, Liou KT, Romero SA, et al. Acupuncture vs massage for pain in patients living with advanced cancer: the IMPACT randomized clinical trial. JAMA Netw Open. 2023;6(11):e2342482.

[17] Harrison JE, Weber S, Jakob R, Chute CG. ICD-11: an international classification of diseases for the twenty-first century. BMC Med Inf Decis Making. 2021;21:1-0.

[18] Farrar JT, Young JP, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001;94:149-158.

[19] Gentile DA, Woodhouse J, Lynch P, Maier J, McJunkin T. Reliability and validity of the Global Pain Scale with chronic pain sufferers. Pain Physician. 2011;14(1):61-70.

[20] Shi C, Ye Z, Shao Z, et al. Multidisciplinary guidelines for the rational use of topical non-steroidal anti-inflammatory drugs for musculoskeletal pain (2022). J Clin Med. 2023;12(4):1544.

[21] McCraken LM, Vowles KE, Eccleston C. Acceptance of chronic pain: component analysis and a revised assessment method. Pain. 2004;107:159-166.

[22] Nicholas MK. The pain self-efficacy questionnaire: taking pain into account. Eur J Pain. 2007;11(2):153-163.

[23] Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361-370.

[24] Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): i. Conceptual framework and item selection. Med Care. 1992;30(6):473-483.

[25] Sutherlin MA, Gage M, Mangum LC, et al. Changes in muscle thickness across positions on ultrasound imaging in participants with or without a history of low back pain. J Athl Train. 2018;53(6):553-559.

[26] Salaffi F, Stancati A, Silvestri CA, Ciapetti A, Grassi W. Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale. Eur J Pain. 2004;8(4):283-291.

[27] Nemati D, Hinrichs R, Johnson A, Lauche R, Munk N. Massage therapy as a self-management strategy for musculoskeletal pain and chronic conditions: a systematic review of feasibility and scope. J Integr Complement Med. 2024;30(4):319-335.

[28] Pan PL, Zhong JG, Shang HF, et al. Quantitative meta-analysis of grey matter anomalies in neuropathic pain. Eur J Pain. 2015;19(9):1224-1231.

[29] Aster HC, Evdokimov D, Braun A, et al. CNS imaging characteristics in fibromyalgia patients with and without peripheral nerve involvement. Sci Rep. 2022;12(1):6707.

[30] Huang YT, Jenkins DA, Peek N, Dixon WG, Jani M. High frequency of long-term opioid use among patients with rheumatic and musculoskeletal diseases initiating opioids for the first time. Ann Rheum Dis. 2023;82(8):1116-1117.

[31] Little P, Lewith G, Webley F, et al. Randomised controlled trial of Alexander technique lessons, exercise, and massage (ATEAM) for chronic and recurrent back pain. BMJ. 2008;337:a2656.

RIGHTS & PERMISSIONS

2024 The Author(s). Clinical and Translational Discovery published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.